These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15246395)

  • 1. Radiography and tomography with fast neutrons at the FRM-II--a status report.
    Bücherl T; Kutlar E; von Gostomski CL; Calzada E; Pfister G; Koch D
    Appl Radiat Isot; 2004 Oct; 61(4):537-40. PubMed ID: 15246395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design of the neutron radiography and tomography facility at the new research reactor FRM-II at Technical University Munich.
    Schillinger B; Calzada E; Grünauer F; Steichele E
    Appl Radiat Isot; 2004 Oct; 61(4):653-7. PubMed ID: 15246413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy-selective neutron radiography and tomography at FRM.
    Kardjilov N; Schillinger B; Steichele E
    Appl Radiat Isot; 2004 Oct; 61(4):455-60. PubMed ID: 15246383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new hybrid thermal neutron facility at TAPIRO reactor for BNCT radiobiological experiments.
    Esposito J; Rosi G; Agosteo S
    Radiat Prot Dosimetry; 2007; 126(1-4):69-73. PubMed ID: 17504745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shielding design for the PANDA spectrometer at the Munich high-flux reactor FRM-II.
    Noack K; Pyka NM; Rogov A; Steichele E
    Radiat Prot Dosimetry; 2005; 115(1-4):262-7. PubMed ID: 16381725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New irradiation facility for biomedical applications at the RA-3 reactor thermal column.
    Miller M; Quintana J; Ojeda J; Langan S; Thorp S; Pozzi E; Sztejnberg M; Estryk G; Nosal R; Saire E; Agrazar H; Graiño F
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S226-9. PubMed ID: 19406651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and calculation of the fast-neutron and photon spectra from the core boundary to the biological shielding in the WWER-1000 reactor model.
    Osmera B; Cvachovec F; Kyncl J; Smutný V
    Radiat Prot Dosimetry; 2005; 115(1-4):92-4. PubMed ID: 16381689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu(n,gamma)177Lu.
    Dvorakova Z; Henkelmann R; Lin X; Türler A; Gerstenberg H
    Appl Radiat Isot; 2008 Feb; 66(2):147-51. PubMed ID: 17900914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determination of reactor neutron spectrum-averaged cross-sections in miniature neutron source reactor facility.
    Jonah SA; Ibrahim YV; Akaho EH
    Appl Radiat Isot; 2008 Oct; 66(10):1377-80. PubMed ID: 18534860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary modeling of BNCT beam tube on IRT in Sofia.
    Belousov S; Ilieva K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S230-3. PubMed ID: 19410473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure vessel calculations for VVER-440 reactors.
    Hordósy G; Hegyi G; Keresztúri A; Maráczy C; Temesvári E; Vértes P; Zsolnay E
    Radiat Prot Dosimetry; 2005; 115(1-4):100-3. PubMed ID: 16381691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRADE experiment: shielding calculations for the building hosting the subcritical system.
    Burn KW; Carta M; Casalini L; Kadi Y; Monti S; Nava E; Palomba M; Petrovich C; Picardi L; Rubbia C; Troiani F
    Radiat Prot Dosimetry; 2005; 115(1-4):187-94. PubMed ID: 16381710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evaluations of the undesirable patient dose from a BNCT treatment at the ENEA-TAPIRO reactor.
    Ferrari P; Gualdrini G; Nava E; Burn KW
    Radiat Prot Dosimetry; 2007; 126(1-4):636-9. PubMed ID: 17704505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The study of physics and thermal characteristics for in-hospital neutron irradiator (IHNI).
    Ke G; Sun Z; Shen F; Liu T; Li Y; Zhou Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S234-7. PubMed ID: 19427794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical shielding calculations for a proton therapy facility.
    Avery S; Ainsley C; Maughan R; McDonough J
    Radiat Prot Dosimetry; 2008; 131(2):167-79. PubMed ID: 18487617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of field trials using the NPL simulated reactor neutron field facility.
    Taylor GC; Thomas DJ; Bennett A
    Radiat Prot Dosimetry; 2007; 126(1-4):89-92. PubMed ID: 17848380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silicon doping system at the research reactor FRM II.
    Li X; Gerstenberg H; Neuhaus I
    Appl Radiat Isot; 2009; 67(7-8):1220-4. PubMed ID: 19324563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hardening neutron spectrum for advanced actinide transmutation experiments in the ATR.
    Chang GS; Ambrosek RG
    Radiat Prot Dosimetry; 2005; 115(1-4):63-8. PubMed ID: 16381683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation analysis of concrete and graphite in the experimental reactor RUS.
    Cometto M; Ridikas D; Aubert MC; Damoy F; Ancius D
    Radiat Prot Dosimetry; 2005; 115(1-4):104-9. PubMed ID: 16381692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The filter/moderator arrangement-optimisation for the boron-neutron capture therapy (BNCT).
    Tracz G; Dabkowski L; Dworak D; Pytel K; Woźnicka U
    Radiat Prot Dosimetry; 2004; 110(1-4):827-31. PubMed ID: 15353754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.